More Closed Doors for NCI Cancer Funding Decisions
Published Date: 3/19/2025
Notice
Summary
The National Cancer Institute is holding several closed virtual meetings in April 2025 to review and decide on important grant applications. These meetings protect private info and trade secrets while helping fund cancer research projects. Researchers applying for grants should note these dates as they impact funding decisions and future cancer studies.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 0 costs, 2 mixed.
Closed grant review meetings in Apr–Jun 2025
The National Cancer Institute will hold multiple closed virtual meetings on April 11; April 16; April 21; May 1-2; May 1; May 9; May 22; June 17-18; and June 26-27, 2025 to review and evaluate grant applications. If you are a researcher who applied for NCI grants, these meetings will determine funding decisions for those applications.
Confidentiality protections for applicants
The meetings will be closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property (such as patentable material), and personal information of individuals named in grant applications. This keeps applicants' sensitive business and personal information from public disclosure during reviews.
K99/R00 and K01 review dates for early postdocs
If you are an early-stage postdoctoral researcher applying for the NCI Pathway to Independence (K99/R00) or the K01 award, your applications will be reviewed in a closed virtual meeting on May 1-2, 2025. That review will influence whether those career-development awards receive funding.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-18191, Submission for OMB Review; 30-Day Comment Request Data and Specimen Hub (DASH) (Eunice Kennedy Shriver National Institute of Child Health and Human Development)
The National Institutes of Health (NIH) is asking for public feedback on their Data and Specimen Hub (DASH), which helps researchers share important health data. This is a quick 30-day review to make sure the information collection is clear and useful. If you’re involved in health research or data sharing, your input by October 8, 2026, can help shape how DASH works without costing extra money or time.
2026-17899, Proposed Collection; 60-Day Comment Request; Assurance (Interinstitutional, Foreign, and Domestic) and Annual Report (Office of the Director)
The NIH wants your thoughts on their plan to keep track of animal research safety through yearly reports and assurances from institutions, both in the U.S. and abroad. This helps make sure labs follow the rules and protect animals, with no new costs or big changes expected. You’ve got until October 2, 2026, to share your feedback and help improve the process!
2026-17687, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in October 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, ensuring fair and confidential decisions. Scientists applying for grants in genetics, molecular sciences, oral health, and cancer research are the ones affected, with no direct cost changes announced.
2026-17438, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings in late September 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers applying for funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
Previous / Next Documents
Previous: 2025-04499, National Cancer Institute; Notice of Closed Meetings
The National Cancer Institute is holding a closed virtual meeting on April 10-11, 2025, to review special grant applications for new cancer research technologies. This meeting affects researchers applying for funding and keeps sensitive info private. No money changes are announced, but the review helps decide who gets research support next.
Next: 2025-04502, Self-Regulatory Organizations; Cboe Exchange, Inc.; Notice of Filing of a Proposed Rule Change To Amend Rule 4.3 To Permit the Listing of Options on Commodity-Based Trust Shares
Cboe Exchange wants to let people trade options on Commodity-Based Trust Shares, which are like special investment units tied to commodities. This change affects investors and traders by giving them new ways to invest and trade starting soon after approval. It’s a smart move to keep Cboe competitive and offer fresh opportunities without extra costs right now.